ArticleScientific reports2026
Effects of testosterone on gene expression in males and females across 40 human tissues.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sex hormones and menopause hormone therapy predict muscle strength across the lifespan.Journal of applied physiology (Bethesda, Md. : 1985) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Variation in testosterone levels is associated with pronounced health risks, often in a discordant manner between males and females. While studies have demonstrated a sex-specific genetic architecture for testosterone, the biological basis for the differential impact on diseases between the sexes is largely unknown. In this study, we correlated predicted testosterone and within-sex gene expression measures across 40 human tissues to identify genes that show sex-differential control of gene expression and examine how this varies across tissues. Gene expression measures were obtained from the Genotype-Tissue Expression project (v8 GTEx release), with sex-specific genome-wide summary statistics from the UK Biobank used to construct polygenic scores as proxies for total testosterone and bioavailable testosterone. We quantified the proportion of variance in the genomically predicted testosterone levels that was captured by gene expression measures within each sex/tissue pair. The association between predicted testosterone measures was tested within each sex/tissue pair for over 20,000 gene transcripts. Gene expression levels in the mammary breast (R2 = 0.54 ± 0.20), adipose (visceral omentum; 0.56 ± 0.21), esophagus (muscularis; 0.42 ± 19) and skin (sun exposed lower leg; 0.34 ± 0.16) tissue explained the largest proportion of total testosterone variance in females, although these estimates were not significant after correction for multiple testing across tissues. Association analyses identified significant associations between total testosterone and gene expression across four transcripts (NUPR1L, PTPRD, PSPHP1, and RP11-208G20.3) in the skeletal muscle, tibial artery, and pancreas tissues for females p < [Formula: see text], whereas no significant associations were observed in males. No transcript or gene showed a significant association with predicted bioavailable testosterone across all study tissues in both males and females. The relationship between testosterone and gene expression levels is complex, showing variation across tissues and between the sexes. While we found limited numbers of associations between individual gene expression levels and predicted testosterone levels, our whole transcriptome approach found that a substantial proportion of testosterone levels could be captured by gene expression levels, indicating that more associations could be identified with larger sample sizes and directly measured hormone levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.